Expression and purification of Canis interferon α in Escherichia coli using different tags

被引:10
作者
Yang, Fang [1 ]
Pan, Yingying [1 ]
Chen, Yazhou [1 ]
Tan, Shiming [1 ]
Jin, Mingfei [1 ]
Wu, Zirong [1 ]
Huang, Jing [1 ]
机构
[1] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China
关键词
Canis interferon alpha; Escherichia coli; Fusion protein; Solubility; Inclusion body; INCLUSION-BODIES; I INTERFERON; CLONING; YIELD; VITRO;
D O I
10.1016/j.pep.2015.07.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The potent and broad activity of Canis interferon a (CaIFN alpha) makes it an attractive candidate for the treatment of many viral diseases of dogs. Here, we fused CaIFN alpha to three different protein tags: thioredoxin (Trx), glutathione S-transferase (GST), and NusA (Nus), to facilitate its expression and purification in Escherichia coli. The Trx-CaIFN alpha and GST-CaIFN alpha fusion proteins formed inclusion bodies, while the Nus-CaIFN alpha, protein was soluble when expressed at low temperatures. Trx-CaIFN alpha was purified from inclusion bodies and refolded, while Nus-CaIFN alpha was purified under native conditions. The purity of Trx-CaIFN alpha and Nus-CaIFN alpha was greater than 90%, and their yields were 74.8% and 6.5%, respectively. Both Trx-CaIFN alpha and Nus-CaIFN alpha had antiviral activity in vitro. Their anti-viral activity was 1.09 +/- 0.47 x 10(14) and 2.25 +/- 0.87 x 10(12) U/mol, respectively, on Madin-Darby canine kidney cells. Both purification methods had advantages and disadvantages. A greater amount of Trx-CaIFN alpha was obtained, but refolding was required to obtain active protein. In contrast, soluble Nus-CaIFN alpha did not require refolding, which saved time and materials. However, Nus-CaIFN alpha, which contained a larger tag, had lower activity than Trx-CaIFN alpha. In general, we provided two protocols to obtain large amounts of CaIFN alpha with high antiviral activity. These protocols may promote the clinical development of CaIFN alpha in treating viral diseases in dog. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 44 条
[1]   Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies [J].
Arora, D ;
Khanna, N .
JOURNAL OF BIOTECHNOLOGY, 1996, 52 (02) :127-133
[2]   Refolding of proteins from inclusion bodies: rational design and recipes [J].
Basu, Anindya ;
Li, Xiang ;
Leong, Susanna Su Jan .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 92 (02) :241-251
[3]   High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a [J].
Bis, Regina L. ;
Stauffer, Tara M. ;
Singh, Surinder M. ;
Lavoie, Thomas B. ;
Mallela, Krishna M. G. .
PROTEIN EXPRESSION AND PURIFICATION, 2014, 99 :138-146
[4]   Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1 [J].
Boasso, Adriano .
SCIENTIFICA, 2013, 2013
[5]   Interferons at age 50: past, current and future impact on biomedicine [J].
Borden, Ernest C. ;
Sen, Ganes C. ;
Uze, Gilles ;
Silverman, Robert H. ;
Ransohoff, Richard M. ;
Foster, Graham R. ;
Stark, George R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :975-990
[6]   Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli [J].
Bu, Dawei ;
Zhou, Yuwei ;
Tang, Jian ;
Jing, Fang ;
Zhang, Wei .
PROTEIN EXPRESSION AND PURIFICATION, 2013, 92 (02) :203-207
[7]  
[曹瑞兵 CAO Ruibing], 2008, [南京农业大学学报, Journal of Nanjing Agricultural University], V31, P107
[8]   Mechanisms underlying the inhibition of interferon signaling by viruses [J].
Devasthanam, Anand S. .
VIRULENCE, 2014, 5 (02) :270-277
[9]  
Guiwei L., 2012, HEILONGJIANG AQUATIC, V1, P38
[10]   STRUCTURE AND EXPRESSION IN ESCHERICHIA-COLI OF CANINE INTERFERON-ALPHA GENES [J].
HIMMLER, A ;
HAUPTMANN, R ;
ADOLF, GR ;
SWETLY, P .
JOURNAL OF INTERFERON RESEARCH, 1987, 7 (02) :173-183